Bronfman E.L. Rothschild L.P. boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 232.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,256 shares of the medical equipment provider’s stock after buying an additional 878 shares during the quarter. Bronfman E.L. Rothschild L.P.’s holdings in Intuitive Surgical were worth $458,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in ISRG. CWM LLC lifted its position in Intuitive Surgical by 200.0% in the 4th quarter. CWM LLC now owns 285 shares of the medical equipment provider’s stock worth $104,000 after buying an additional 190 shares in the last quarter. American National Bank lifted its position in Intuitive Surgical by 200.0% in the 4th quarter. American National Bank now owns 300 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 200 shares in the last quarter. Spectrum Management Group Inc. lifted its position in Intuitive Surgical by 154.2% in the 4th quarter. Spectrum Management Group Inc. now owns 300 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 182 shares in the last quarter. Trust Department MB Financial Bank N A lifted its position in Intuitive Surgical by 200.0% in the 4th quarter. Trust Department MB Financial Bank N A now owns 345 shares of the medical equipment provider’s stock worth $126,000 after buying an additional 230 shares in the last quarter. Finally, Cerebellum GP LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $127,000. Institutional investors own 36.79% of the company’s stock.
Intuitive Surgical, Inc. (NASDAQ ISRG) opened at $402.00 on Wednesday. Intuitive Surgical, Inc. has a 12 month low of $236.75 and a 12 month high of $452.00. The stock has a market cap of $45,040.00, a price-to-earnings ratio of 70.77, a P/E/G ratio of 4.63 and a beta of 0.50.
Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.27. Intuitive Surgical had a net margin of 21.09% and a return on equity of 19.93%. The business had revenue of $892.40 million for the quarter, compared to analyst estimates of $866.54 million. During the same period last year, the business posted $2.03 EPS. Intuitive Surgical’s revenue was up 17.9% compared to the same quarter last year. equities research analysts expect that Intuitive Surgical, Inc. will post 7.93 EPS for the current year.
A number of equities research analysts have issued reports on ISRG shares. Barclays reiterated an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, October 20th. BidaskClub lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, December 12th. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 price target on the stock in a research note on Tuesday, December 12th. Royal Bank of Canada increased their price target on shares of Intuitive Surgical to $430.00 and gave the stock a “sector perform” rating in a research note on Friday, January 26th. Finally, Canaccord Genuity restated a “hold” rating and set a $410.00 price target (up previously from $380.00) on shares of Intuitive Surgical in a research note on Friday, January 26th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Intuitive Surgical presently has a consensus rating of “Buy” and a consensus target price of $408.48.
In related news, EVP Curet Myriam sold 262 shares of the firm’s stock in a transaction on Tuesday, January 30th. The shares were sold at an average price of $431.50, for a total value of $113,053.00. Following the transaction, the executive vice president now directly owns 2,152 shares in the company, valued at approximately $928,588. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Gary S. Guthart sold 7,724 shares of the firm’s stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $414.50, for a total transaction of $3,201,598.00. Following the completion of the sale, the chief executive officer now owns 275,220 shares in the company, valued at $114,078,690. The disclosure for this sale can be found here. Insiders sold a total of 85,016 shares of company stock worth $35,133,026 over the last quarter. 2.20% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY WARNING: “Intuitive Surgical, Inc. (ISRG) Shares Bought by Bronfman E.L. Rothschild L.P.” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark law. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/14/intuitive-surgical-inc-isrg-shares-bought-by-bronfman-e-l-rothschild-l-p.html.
Intuitive Surgical Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.